Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
Status
Conditions
Treatments
Details and patient eligibility
About
The Anaphylaxis Registry aims to assess data in a standardized form about symptoms, triggers, cofactors and therapy management from patients who experienced an anaphylactic reaction. This should improve diagnosis and long-term management of these life-threatening allergic reactions.
Full description
A better understanding of the triggers and pathology of anaphylactic reactions could lead to a better diagnosis and prophylaxis to avoid the occurence of these life-threatening allergic reactions. This can be an advantage for affected persons regarding the their treatment and long-term management.
The Anaphylaxis Registry is an opportunity to gather these standardized data. The blood sampling is optional for the patient, however, it will contribute to the better understanding of the sensitization profile and possible mechanisms. Recent publications showed a correlation between an anaphylactic reaction and certain biomarkers. Those data will be validated in a larger number of population with identification of further biomarkers. It is presumed that certain genetic and epigenetic polymorphisms are abundant for patients who experienced an anaphylaxis.
To summarize, this study aims to contribute to a better understanding of the anaphylaxis in general, the diagnosis, and the prognosis with different severities. With the identification of a certain trigger, the obtained understanding may help to decrease the risk of or prevent future repeating reactions.
Enrollment
Sex
Volunteers
Inclusion criteria
- Anaphylactic reaction within the past 12 months
Exclusion criteria
Trial design
20,000 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Margitta Worm, Prof.; Sabine Dölle-Bierke, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal